Media Resources

30 September

Early Access to Medicines Marketing Authorisation Flexibilities Should Only Respond to Unmet Medical Needs, Must Protect Patient Safety

16 September

Direct Patient Reporting in the EU: A Snapshot of Reporting Systems in Seven Member States

18 August

Declaration of Public Interest Regarding Access to Imatinib (Glivec) in Colombia

8 July

Health Action International Opposes European Parliament’s ISDS Compromise in TTIP

7 July

EU Medicines Policy and Access to Medicines

29 June

HAI Sexual Harassment Policy

23 June

Health Action International Launches New Brussels Office

16 June

Health Action International Criticises JURI Support for EU Trade Secrets Directive Report

14 April

How TTIP Could Damage Access to Affordable Medicines in the European Union

15 March

Assessing the Nature, Extent and Impact of Regulation of Medicines Promotion

3 March

2014 Annual Report and Financial Statements

1 March

2014 Annual Report and Financial Statements

18 February

EU Clinical Trials Regulation: EMA Steers Away from Transparency by Misinterpreting Exception Provisions

22 October

Retention of Medicines Policy in DG Health a Victory for Public Health Advocates

16 October

EMA’s Final Policy on Access to Clinical Data: Proactive Access to Some Data, But Strings Attached

14 October

EU Pharmacovigilance Public Hearings Should Be As Transparent and Independent as in US

29 September

Trading Away Access to Medicines – Revisited

29 September

Europe Seeks to Expand Big Pharma Monopoly at Expense of Poor People, Warn NGOs Ahead of TTIP Talks (2014)

12 September

Public Health in Danger with Move of Pharmaceutical Policy to DG Enterprise and Industry

1 September

Mapping External Reference Pricing Practices for Medicines

14 July

Investor-State Dispute Settlement in EU-US Trade Deal Risks Access to Affordable Medicines

24 June

EMA’s New Policy on Access to Clinical Data – About to Privatise Pharmaceutical Knowledge?

3 April

Health Action International Welcomes Adoption of New Clinical Trials Regulation by European Parliament

3 April

Health Action International Applauds Medicines Patent Pool, ViiV Healthcare Licensing Agreement for New HIV Treatment

24 March

The EU-US Trade Agreement – Proposals by Pharmaceutical Industry Undermine European Public Policymaking and Public Health

17 March

EU Regulation on Clinical Trials – Close to the Finish Line

3 March

2013 Annual Report and Financial Statements

1 March

2013 Annual Report and Financial Statements

1 February

Working Paper 4 – Competition Policy

1 February

Policy Brief 3 – Regulation of Mark-ups in the Pharmaceutical Supply Chain